Prevalence of risk factors of coronary disease in personnel of the General Hospital of Mexico;Prevalencia de factores de riesgo de enfermedad coronaria en trabajodores del Hospital General de Mexico

Salud Publica de Mexico

Volumn 39, Issue 5, 1997, Pages 427-432

  Fanghänel Salmón, Guillermo ^a,d   Sánchez Reyes, Leticia ^b   Arellano Montaño, Sara ^b   Valdés Liaz, Eulalia ^b   Chavira López, Javier ^b   Rascón Pacheco, Ramón Alberto ^c  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d NONE   (Mexico)

Author keywords

Coronary disease risk factorsPrevalence; Health personnel; Mexico

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEXICO; OBESITY; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

EID: 0030780456     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-36341997000500005     Document Type: Article

References (45)

1. Instituto Nacional de Estadística, Geografía e Informática. Cuaderno núm. 10. México, D.F.: INEGI, 1994.
2. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950.World Health Stat Q 1988;41:155-178.
3. Lozano-Ascencio R, Escamilla-Cejudo JA, Escobedo-de la Peña J, López-Cervantes M. Tendencia de la mortalidad por cardiopatía isquémica en México de 1950 a 1985. Salud Publica Mex 1990,32:405-415.
4. Subsecretaría de Planeación, Secretaría de Salud. Mortalidad 1995. México, D.F.: SSA; 1996:69.
5. Stern MR Bradshaw BS, Eipler CW, Fong DS, Hazuda HP, Ropsenthal M. Secular decline in death rates due to ischemic heart disease in Mexican American and non Hispanic whites in Texas, 1970-1980. Circulation 1987;76:1245-1250.
6. Lewis B. Frecuency of risk factors for ischaemic heart disease in a healthy British population. Lancet 1974;2:141-146.
7. Zorrilla E. Factores de riesgo coronario en la población mexicana. Arch Inst Cardiol Mex 1985;55:405-409.
8. Cueto G. Prevención de ateroesclerosis coronana. Prevalencia de factores de riesgo en burócratas de la Ciudad de México, D.F. Arch Inst Cardiol Mex 1989;59:19-27.
9. Castelli WP, Anderson K. A population at risk. Prevalence of high cholesterol levels in hipertensive patients in the Framingham Study. Am J Med 1986;80:23-32.
10. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-58
11. Kannel WB, Castelli WP, Gordon T. Serum cholesterol, lipoproteins, and the risk of coronary heart disease The Framingham Study. Ann Int Med 1971;74:1-12.
12. The Second Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA 1993;269:3015-3023.
13. Study Group, European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 1987,8:77-88.
14. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB et al. Overall and CHD mortality rates in relation to major risk factors in 325 348 men screened for the MARFIT. Am Heart J 1986;112:825-836.
15. Jorde LB, Williams RR. Relation between family history of coronary artery disease and coronary risk variables. Am J Cardiol 1988;62:708-713.
16. Report of the National Cholesterol Education Program. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. The expert panel Arch Intern Med 1988;148:36-69.
17. Frick MH, Elo O, Haapa K. Helsinki heart study N Engl J Med 1987, 317:1237-1245.
18. Silva-Ayaguer LC. Excursión a la regresión logística en ciencias de la salud. Madrid: Ediciones Díaz de Santos, 1995.
19. Encuesta Nacional de Enfermedades Crónicas. México, D.F.: Secretaría de Salud, 1993.
20. Cueto GI, Brito E, Barrera GJ. Prevalencia de factores de riesgo en burócratas en la Ciudad de México. Arch Inst Cardiol Mex 1989;59:19-27.
21. Zorrilla E. Hipercolesterolemia. Diagnóstico y tratamiento. Hipercolesterolemia en México. 2a. edición. México D.F.: Editorial Interamericana, 1995:69-96.
22. Peter WF, Wilson MD. The impact of triglycerides on coronary heart disease: The Framingham Study. En: Triglycerides, the role in atherosclerosis; 1990 mayo; Austria Center, Viena. Book of Abstracts 15-12.
23. Lewis B, Chait A, Oakley CMO. Serum lipoprotein abnormalities in patients with control population. Br Med J 1974;3:489-493.
24. Goldstein JL, Hazzard WR, Schortt HG. Hyperlipidemia in coronary heart disease. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 1973;52:1533-1543.
25. Heyden S. The problem with triglycerides. Nutr Metab 1975;18:15.
26. Assman G, Schulte H. PROCAM-TRIAL: Prospective cardiovascular münster trial. Munich: Mmv Medizine Verlag, 1989:1-73.
27. Neaton JD , Kuller LH, Wentworth D. Total and cardiovascular mortality in relation to smoking, serum cholesterol concentration and diastolic blood pressure among blanc and white males followed up for five years. Am Heart J 1984;108:759-769.
28. Tyroler HA, Heyden S. Blood pressure and cholesterol as coronary heart disease risk factors. Arch Int Med 1971;128:907-914.
29. Hammond EC, Garfinkel L. Coronary heart disease, stroke and aortic aneurysm. Arch Environ Health 1969;19:167-174.
30. Zubirán S, Chávez A. Estudio epidemiológico de la diabetes en la Ciudad de México. Rev Invest Clin 1964;16:367-383.
31. Zorrilla E, Hernández A, Chávez-Domínguez R. Factores nutricionales y metabólicos de riesgo coronario en trabajadores industriales mexicanos. Memorias del 90. Congreso Internacional de Nutrición; 1972; México, D.F.
32. Fanghanel G, Arellano S, Villalobos S. Epidemiología de la diabetes mellitus en el Hospital General de México de la SSA. Rev Med Hosp Gen Mex 1983;46:76-86.
33. González C, Stern MP, Villalpando E. Prevalencia de diabetes e intolerancia a glucosa en una población urbana de nivel socioeconómico bajo. Rev Invest Clin 1992;44:321-328.
34. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979;241:2035-2038.
35. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
36. Cordon T, Kannel WB, Hjortland MC. Menopause and coronary boart disease: The Framingham Study. Ann Intern Med 1978;89:157-161.
37. Mattbewb KA, Meilahn E, Kuller LB. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:640-646.
38. Campos B, McNamara Jr, Wilson PW Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and posmenopausal women. J Clin Endocrinol Metab 1988;67:30-35.
39. Willett WC, Green A, Stampfer MJ. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987;317 1303-1309.
40. Manson JE, Tosteson H, Ridker PM. The primary prevention of myocardial infarction. N Engl J Med 1992;326 1406-1416.
41. Hebert PR, Moser M, Mayer J. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-581.
42. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991;265:3255-3264
43. Manson JE, Colditz GA, Stampfer MJ. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990,322:882-889.
44. Salonen JT, Puska P, Tuomilehto J. Physical activity and risk of myocardial infarction, cerebral stroke and death: A longitudinal study in Eastern Finland. Am J Epidemiol 1982;115:526-537.
45. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women: The postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1995;273:199-208.